Signaling pathways and proteins targeted by antidiabetic chalcones

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Chalcones possess diverse biological activities, including significant clinical potential for various diseases.
• Their therapeutic effects are often linked to the α, β-unsaturated carbonyl system, acting as Michael acceptors.
• This review focuses on the antidiabetic properties of chalcones.

Purpose of the Study:

• To review the antioxidant potential of chalcones.
• To elucidate the mechanisms and molecular targets of antidiabetic chalcones, including carbohydrate digestive enzymes (α-amylase, α-glucosidase), aldose reductase, SGLT-2, and Nrf2.
• To explore the insulin mimetic potential and therapeutic implications of chalcone targets.

Main Methods:

• Literature review of chalcone biological activities and mechanisms.
• Analysis of chalcones' interactions with key proteins and pathways involved in diabetes.
• Exploration of advanced techniques like RNA interference and in silico molecular docking for novel drug discovery.

Main Results:

• Chalcones exhibit antioxidant properties and modulate critical antidiabetic targets.
• They demonstrate insulin mimetic potential and influence pathways regulating glucose metabolism.
• The α, β-unsaturated carbonyl system is crucial for their biological activity.

Conclusions:

• Chalcones represent a promising class of compounds for developing novel antidiabetic therapies.
• Understanding their molecular targets and mechanisms provides a basis for rational drug design.
• Advanced computational and genetic techniques can accelerate the discovery of more potent antidiabetic chalcones.